Inpharma Weekly

, Volume 1409, Issue 1, pp 8–8 | Cite as

Darifenacin may prolong warning time in patients with overactive bladder syndrome

Media release


Placebo Multicentre Study Placebo Recipient Medium Release Overactive Bladder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2003

Personalised recommendations